But few examples1* could be found containing the "siderophore" at C-3 which facilitates the introduction of antibacterial agents into a bacterial cell by the iron-transport channel mechanism.
2) It was reported3'40 that aminothiazolylcephalosporins bearing dihydroxyaromatic moiety, e.g. catechol or l,5-dihydroxy-4-pyridone, exhibit potent activity against Gram-negative bacteria including Pseudomonas aeruginosa. Thus we prepared 7-aminothiazolyl-3-vinylcephalosporins la~lj having a catechol substituent linked to the vinyl group via an isoxazole moiety, which is known to enhance activity against Gram-positive bacteria, to achieve a balanced antibacterial spectrum and investigated their Reagents i)6, 5% NaHCO3/ CH2C12, 65%(Z/E=~9:1) ii)PCl5, Py, 84% iii)10, pTsCl, Et3N, 53-62% iv)TFA, Anisole v)7% NaHCO3, 58-66% (2 steps) dichlorocatechol moiety which was knownto improve the stability to catechol-O-methyl-transferase (COMT), 6) were synthesized from 2,5-dichloro-3,4-dihydroxybenzaldehyde (2, X = Cl) following the same synthetic pathway described above (Scheme 2). Cephalosporins lk7) and ll were also synthesized for better understanding of the effect of structural modification.
Biological Studies MICs of the new catechol type cephalosporins against both Gram-positive and Gram-negative strains were determined by the two-fold Mueller-Hinton agar dilution method,8) and the results for selected strains are collected in Table 1 . The MICvalues ofcefotaxime and cefpirome are also presented for comparison.
In Table 1 , almost all the cephalosporins prepared showed balanced antibacterial activity against both Gram-positive and Gram-negative bacteria except against S.faecium which is known to be strongly resistant to cephalosporin family. Of the two series of cephalosporins, one bearing the unsubstituted catechol (la~le) showed more potent activity against Gram-positive bacteria than another with dichlorocatechol (lf~lj).
Except la and If having hydroxyimino group at C-7 substituent, all the other cephalosporins exhibited antipseudomonalactivity superior to both cefotaxime and cefpirome. And the compounds lc~le and lh~lj possessing a carboxyl group on the C-7 side chain showed potent activity against Gram-negative strains, though they showed somewhat less activity against E. cloacae, possibly due to the polar nature of the carboxyl substituent. The catechol substituent enhanced the antipseudomonal activity as expected, which was also confirmed by comparing activity of Ik and ll. However, the results against the other strains were unsatisfactory.
The effect of isoxazole componentcould be measured by comparing the antibacterial activities of lb with those of ll which only lacks the isoxazole spacer. By simply adding the isoxazole moiety between vinyl and catechol substituents, lb gained large enhancement in activity against both Gram-positive and Gram-negative strains. This was confirmed by the results for the strains S. pyogenes and S. typhimurium, for which the increases in MIC values were ca. fifty-and one hundred-fold, respectively.
Considering both potency and well-balanced spectrum of antibacterial activity, lb demonstrated optimal activity. It showed equivalent or superior activity to cefotaxime and cefpirome against all the strains tested except E. cloacae. The antibacterial activity of la against
Gram-positive bacteria, especially S. faecium, was excellent, but it showedpoor activity against K. oxytoca and E. cloacae. Pharmacokinetic parameters obtained via im and iv administration of la~le are listed in Table 2 . Large differences depending on the administration route were observed in the Cmax and the AUCvalues, probably because of differing level of absorption, while the Conditions: solvent=saline; medium=Mueller-Hinton agar; microorganism=E. coli 1507E; amount =40 (mg/kg); animal = female ICR mice, mean body weight=25.4g, 4~6 mice per group. reference compoundcefpirome gave results irrespective of the administration route. The AUCvalues for both la and lb via iv administration were comparable to that for cefpirome.
